The Pharmacotherapy For Cardiovascular Disorders Essay
1 Pharmacotherapy for Cardiovascular Disorders Student’s Name Institution Affiliation Course Name Professor’s Name Date PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDERS 2 Pharmacotherapy for Cardiovascular Disorders Influence of Selected Factor Cardiovascular disease is one of the leading causes of death in the entire world. However, the prevalence of disorders associated with heart disease in the United States is alarming due to the healthcare system’s threats. Nevertheless, cardiovascular ill patients do not get optimal care, even with the recent progress in treatment. The provided case study involves a patient known as AO. The patient has been suffering from obesity and has added weight by 9 pounds. Recently, AO was diagnosed with hyperlipidemia and hypertension.
The patient’s prescribed medicines include Doxazosin 8 mg, sertraline 25mg, atenolol 12.5 mg, simvastatin 80mg, and hydralazine 10mg qid. The drugs are taken daily. The primary factor that may influence pharmacokinetic and pharmacodynamics processes the patient is behavioral factors. Thus, the patient’s obesity history o can be linked to high dietary intake in calories with less physical exercise. The patient’s recent diagnosis with hypertension is attributable to the pathophysiology of obesity. Hyperlipidemia in an obese patient makes it difficult to manage cardiovascular diseases. The patient’s unbalanced diet, combined with poor circulation, impacts the pharmacokinetics and pharmacodynamics processes The Pharmacotherapy For Cardiovascular Disorders Essay